| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $28.0M | +65.9% |
| Cost of Revenue | $6.9M | +45.7% |
| R&D Expense | $12.3M | +37.6% |
| SG&A Expense | $20.5M | -12.5% |
| Operating Income | -$26.1M | +5.5% |
| Interest Expense | $873K | +170.9% |
| Pre-tax Income | -$25.9M | +2.2% |
| Income Tax | $24K | +6.5% |
| Net Income | -$26.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.3M | -82.2% |
| Short-term Investments | $17.4M | +40.3% |
| Accounts Receivable | $2.5M | +30.8% |
| Current Assets | $26.9M | -25.2% |
| Total Assets | $46.3M | -18.6% |
| Current Liabilities | $8.4M | +22.8% |
| Total Liabilities | $33.8M | +6.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.8M | +49.1% |
| Capital Expenditures | $1.7M | +18.6% |
| Investing Cash Flow | -$6.5M | -530.3% |
| Financing Cash Flow | -$101K | -100.3% |
| Free Cash Flow | -$10.5M | +43.9% |
| +2.2% |
| EPS (Basic) | -$0.81 | +10.0% |
| EPS (Diluted) | -$0.81 | +10.0% |
| Stockholders' Equity |
| $12.4M |
| -50.6% |